Cohance Lifesciences Limited (NSE:COHANCE)
381.50
+6.50 (1.73%)
At close: Jan 28, 2026
Revenue by Product
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Revenue by Geography
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.